EX-99.1 2 ex99-1.htm EX-99.1 Exhibit 99.1 Stereotaxis Reports 2025 Full Year Financial Results St. Louis, MO, March 9, 2026 (Globe Newswire) - Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial results for the fourth quarter and full year ended December 31, 2025. “The past year saw tremendous progress with significant regulatory approvals globally, advancement of a broad pipeline of innovations, and revenue growth of over 20%. I’m proud of what our team has accomplished and excited for the year ahead,” said David Fischel, Chairman and CEO. “The highlight of the past year was achieving regulatory approvals in the United States and Europe for the GenesisX robot, MAGiC ablation catheter, and MAGiC Sweep high density mapping catheter. This core product portfolio serves as a foundation for significant commercial growth as the only robotic technology in the attractive electrophysiology market.” “The commercial contribution from these new products was modest in 2025 as we worked through challenges in ramping manufacturing of MAGiC and GenesisX. Our primary goals this year are to dem…
Open exhibit ↗Current Report · Items 2.02, 9.01 · 8-K
Stereotaxis, Inc.
STXSNYSE_AMERICANEQUITYCurrent
Results of Operations and Financial Condition
Item Results 2.02 of Operations and Financial Condition On March 9, 2026, Stereotaxis, Inc. (the “Company”) issued a press release (the “Earnings Press Release”) setting forth its financial results for the 2025 fourth quarter and full year. A copy of the Earnings Press Release is being filed as Exhibit 99.1 hereto, and the statements contained therein are incorporated by reference herein.
Disclosure sections
Item 2.02Item 2.02 - Results of Operations
Item Results
2.02 of Operations and Financial Condition
On
March 9, 2026, Stereotaxis, Inc. (the “Company”) issued a press release (the “Earnings Press Release”)
setting forth its financial results for the 2025 fourth quarter and full year. A copy of the Earnings Press Release is being filed as Exhibit
99.1 hereto, and the statements contained therein are incorporated by reference herein.